source
- Moderna, after losing US funding, rebounds to start mRNA bird flu vaccine trialA program that got caught up in HHS’ decision to abandon mRNA research was revived by a public-private coalition and is now beginning a large, late-stage test that could support a future approval.BioPharma Dive · 4mo ago↗ source
- Merck adds to pharma’s AI push; Roche details MS drug resultsMerck is making a $1 billion investment in a deal with Google Cloud. Elsewhere, Roche pitched its case for a closely watched multiple sclerosis pill and Arcus and Gilead are ending a yearslong alli…BioPharma Dive · 4mo ago↗ source
- An ‘AI scientist’ can tackle drug R&D. What does that mean for pharma?A new tool is giving researchers a “data center full of genius Ph.D. students in their pocket.”BioPharma Dive